9B6-27717-88057
3 vaccinations
5 coded responses
38 check-ins
5 free-text entries
3 call cases
- Sex
- Female
- Age at first dose
- 41-45
- ZIP prefix
- 195 / PA
- Registered
- 2020-12-27
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-26
Dose 1 — Moderna
-
2020-12-27
Registered in v-safe
-
2020-12-27
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain, Redness, Swelling · Fatigue or tirednessAdult check-in
-
2020-12-28
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain, Redness, Swelling · Fatigue or tirednessAdult check-in
-
2020-12-29
Survey response — days 1–6 daily, dose 1MedDRA: Injection site reaction — Feeling: Good · Fatigue or tirednessFree text: Injection site symptoms went away after 48 hoursMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2020-12-30
- 2020-12-31
- 2021-01-01
-
2021-01-02
Survey response — day 7, dose 1MedDRA: Medical counselling — Feeling: Good · Site: Redness, Swelling, Itching · None · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Just submitted an asynchronous e-visitMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-02
Report sent to call center — day 7, dose 1Get care from a doctor or other healthcare professional1 call case(s)
-
2021-01-09
Survey response — day 14, dose 1MedDRA: Cellulitis, Impaired work ability, Injection site infection — Feeling: Fair · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visitFree text: Injection site became infected 1 week after getting vaccine. Diagnosed as probable cellulitis. Currently taking medication and am out of work. Next follow up appt is 1/14/2021.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-09
Report sent to call center — day 14, dose 1Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
- 2021-01-16
- 2021-01-23
-
2021-01-29
Call successfulReported to VAERS voluntarily prior to GDIT contact
-
2021-01-30
Dose 2 — Moderna
- 2021-01-30
-
2021-01-31
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain, Swelling · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
-
2021-02-01
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
- 2021-02-02
-
2021-02-03
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
- 2021-02-04
-
2021-02-05
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Headache, Fatigue or tiredness, Vomiting · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
- 2021-02-06
- 2021-02-13
-
2021-02-20
Survey response — day 21, dose 2MedDRA: Dyspepsia, Fatigue — Feeling: FairFree text: Fatigue and a bit of a sour stomach off and on. Not sure if related to vaccine or not.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-27
- 2021-03-06
- 2021-03-13
- 2021-05-01
-
2021-07-31
Survey response — 6 months, dose 2MedDRA: Eye pain, Magnetic resonance imaging head abnormal, Visual impairment — Feeling: Fair · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Eye pain and diminished vision in left eye, abnormal brain MRI. Being evaluated for MS.MedDRA releases: 2021-09,2024-11 · check-in free text available
-
2021-07-31
Report sent to call center — 6 months, dose 2Get care from a doctor or other healthcare professional1 call case(s)
- 2021-08-04
- 2021-08-11
-
2021-11-12
Dose 3 — Moderna
-
2021-11-14
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Pain, Redness, Swelling · Fatigue or tirednessAdult check-in
-
2021-11-15
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Pain, Redness, Swelling, Itching · Fatigue or tirednessAdult check-in
-
2021-11-16
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Pain, Redness, Swelling · Fatigue or tirednessAdult check-in
-
2021-11-17
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
- 2021-11-19
- 2021-11-26
- 2021-12-03
- 2021-12-10
- 2021-12-17
- 2021-12-26
- 2022-02-13
- 2022-05-13
- 2022-11-13
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-26 | Moderna | |
| 2 | 2021-01-30 | Moderna | |
| 3 | 2021-11-12 | Moderna | No |
Call center
3 call center cases
2 successful · 1 unsuccessful
VAERS report filed, before or during a call: 2
Free text
Release 1 — days 1–6 daily, dose 1
Systemic reaction (other): Injection site symptoms went away after 48 hours
Release 1 — day 7, dose 1
Healthcare visit (other): Just submitted an asynchronous e-visit
Release 1 — day 14, dose 1
Symptoms: Injection site became infected 1 week after getting vaccine. Diagnosed as probable cellulitis. Currently taking medication and am out of work. Next follow up appt is 1/14/2021.
Release 4 — day 21, dose 2
Symptoms: Fatigue and a bit of a sour stomach off and on. Not sure if related to vaccine or not.
Release 9 — 6 months, dose 2
Symptoms: Eye pain and diminished vision in left eye, abnormal brain MRI. Being evaluated for MS.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Medical counselling | ✓ | ✓ | ✓ |
| SD | Cellulitis | ✓ | ✓ | ✓ |
| SD | Dyspepsia | ✓ | ✓ | ✓ |
| SD | Eye pain | ✓ | · | ✓ |
| SD | Fatigue | ✓ | ✓ | ✓ |
| SD | Impaired work ability | ✓ | ✓ | ✓ |
| SD | Injection site infection | ✓ | ✓ | ✓ |
| SD | Magnetic resonance imaging head abnormal | ✓ | · | ✓ |
| SD | Visual impairment | ✓ | · | ✓ |
| SRO | Injection site reaction | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release